Objectives-To determine whether a single high dose ofvitamin A given to all children in communities with high mortality and malnutrition could affect mortality and to assess whether periodic community wide supplementation could be readily incorporated into an ongoing primary health programme.
Introduction
Vitamin A deficiency has been suggested as a possible risk factor for childhood illness and death. Studies from Indonesia, India, and the lowlands of Nepal indicated that wide scale supplementation with vitamin A reduced child mortality in deficient populations," though a recent Indian study found no beneficial effect.5 These programmes were carried out as large single intervention research studies, and it is not clear whether vitamin A supplementation could be incorporated into ongoing primary health care services without adding considerably to the cost.
The benefits of routine vitamin A supplementation in preventing blindness are well documented, and supplementation is warranted wherever substantial xerophthalmia is found.6 During a three year intervention trial of management of pneumonia in Jumla district, Nepal,7 eye signs suggestive of severe xerophthalmia in the period preceding death were often reported in the more than 2000 verbal postmortem reports. Despite earlier studies of xerophthalmia in Nepal reporting that vitamin A deficiency was not a major problem in mountainous areas,8 this observation suggested that serious deficiency might exist.
At the end of the pneumonia trial we initiated routine periodic vitamin A supplementation for all children under 5 years. Because new field implementation systems were required and immediate full coverage was impracticable the programme was phased in over six months, resulting in an initial period in which only half the children were given supplementation. We assessed the difference in mortality between supplemented and unsupplemented populations and analysed the cost and impact on the health programme.
Subjects and methods
Jumla district lies in a remote mountainous region of northwestern Nepal. The district's population is about 80 000, with 12 000 children under 5 years. It is one of the poorest and most medically underserved areas of the country. Child mortality is extremely high, with an infant mortality of 189 deaths per 1000 live births and a death rate in children aged 1-4 years of 52 per 1000 children per year.7 Malnutrition is prevalent, and 26% of children aged 1-4 years have arm circumferences indicating substantial malnutrition (< 12-5 cm)' 9; exclusive breast feeding up to 6 months is universal. In a survey of 3651 children under 5 years, active xerophthalmia was detected in 13-2%'°; xerophthalmia among infants was 1-5%, which is high for this age group. Diarrhoea and pneumonia are the leading causes of death in children after the first week of life.7
Full registration of vital events (births, deaths, and disease) had been done in 16 
Results
The eight supplemented subdistricts had a total of 3786 children aged under 5 at the start of observation, the eight unsupplemented subdistricts had a total of 3411 children; the baseline composition in age and sex were virtually identical (table I). Over the past two years the supplemented subdistricts had shown slightly higher mortality than the unsupplemented, but the difference was small and not significant (table II) . Seasonal variation in mortality was high, related to overall food deficit and the high rate of diarrhoeal disease transmission during the summer, and similar between the two sets of subdistricts.
During the supplementation campaign 3345 (88%) of the 3786 eligible children received vitamin A. There were no reported refusals, and a child's extended absence from the home was the principal reported reason for failure to give vitamin A. All children were followed up as part of the routine pneumonia case management programme, and about 2% of those who received vitamin A supplementation were reported to have experienced vomiting, fever, or diarrhoea within a few days after receiving vitamin A. However, as there is a high prevalence of gastroenteritis and diarrhoea in the summer, these symptoms could not be clearly attributed to vitamin A. There were no reported serious toxic reactions, even among very young infants.
During June-October 1989 the relative risk of death among the supplemented population compared with the unsupplemented population was 0 74 (95% confidence interval 0-55 to 0-99, p<0 05) for a 26% reduction in childhood mortality among the supplemented population after a single dose of vitamin A (table III) . The effect of clustering on the analysis was to increase the width of the confidence interval by 19% over the usual Poisson confidence interval. In all, 138 deaths occurred in the supplemented group and 167 in the unsupplemented group, giving death rates of 93 and 126 deaths per 1000 child years at risk, respectively. Differences in. mortality could be seen within a few days of supplementation but continued to widen with time ( figure) .
The effect of supplementation seemed to be greatest among children aged 6 to 11 months (relative risk 0 51, 95% confidence interval 0 30 to 089), but was also apparent in all older age groups. Among infants aged 1-5 months, the point estimate of relative risk of death was 099 but the confidence interval was wide (0-41 to 2-41). The effect of supplementation on mortality was similar for both sexes. Boys and girls in the supplemented population showed a relative risk of death of 072 and 0-76, respectively compared with the unsupplemented population.
Analysis of causes of death according to verbal postmortem reports indicated that the greatest decrease The size of the protective effect in infants aged 6-12 months (49% reduction in mortality) was greater than has been reported by other studies34 and may reflect the harsh nutritional environment of infants in Jumla. Foods rich in vitamin A are not a part of the Jumla diet, and mothers commonly report night blindness during pregnancy, suggesting that even gestational and lactational stores may be limited. Weaning traditionally begins at 6 months, resulting in a decrease of vitamin A from breast milk. These factors may also explain the unusual finding of a 1-5% rate of active xerophthalmia among infants.'0 Supplementation of vitamin A starting in early infancy may be warranted among similar populations with high levels of xerophthalmia and general malnutrition. We found no significant adverse consequences associated with giving high doses to infants. The power of our study was not sufficient to determine benefit for infants aged less than 6 months; the point estimate of relative risk was 0 99 for this age group but the lower limit of the 95% confidence interval was 0-41, so we cannot rule out a sizable effect. As earlier studies have indicated that the effect of supplementation may be cumulative and increase over time,4 the effect on this age group may not become apparent until the population has been followed for longer. The death rate observed in the unsupplemented population was consistent with data collected during the same months in the previous two years, which makes it unlikely that factors unrelated to the programme significantly affected mortality in unsupplemented communities. The low mortality from measles, the commonest cause of epidemics in this population, also supports this. Observer (Hawthorne) effect is not likely to have contributed to the difference in mortality as apart from the one visit to give vitamin A the amount of contact with health workers did not differ between the two groups and all households throughout the district continued to be visited every two weeks for detection and treatment of pneumonia.
VITAMIN A AND DISEASE
Earlier studies have reported an association between vitamin A status and the risk of illness or death from specific infections, notably diarrhoea, pneumonia, and measles.'5I`8 Our study strongly supports the association with deaths from diarrhoeal diseases but the effect on deaths from pneumonia and measles was less clear. The predominant influence on deaths from diarrhoeal disease, both in terms of absolute numbers and in percentage reduction, is not surprising given the close relation between diarrhoea and malnutrition.'9 This finding indicates that if a sustained year round vitamin A supplementation programme is not feasible in malnourished populations with a high child mortality vitamin A would best be targeted at the period preceding seasons in which morbidity and mortality from diarrhoea are at their peak.
Even though an equivalent impact on mortality from pneumonia could not be clearly determined due to the wide confidence interval, a smaller proportional effect on mortality from pneumonia is consistent with the age related reduction in mortality we observed. Registration of vital events among this population has shown that most deaths from pneumonia occur before the age of 6 months,7 the age group in which a reduction in mortality after vitamin A supplementation was not evident. Effect on mortality from pneumonia may also have been reduced by the fact that an active programme of antibiotic management of pneumonia was ongoing throughout both the supplemented and unsupplemented population, minimising deaths from this cause. The number of deaths from measles during the observation period was too small to give a clear indication of effect; generally measles epidemics are not common in Jumla during the summer.
Both regular low dose vitamin A supplementation23 and periodic (four to six monthly) high dose supplementation'4 have been found to reduce mortality in childhood. The effect of low dose supplementation indicates the potential impact of including more foods rich in vitamin A in the diet, but fundamental behavioural change at the household level can be accomplished only over several years, during which time children would continue to die needlessly. We have shown that periodic supplementation is effective, if necessary even on an emergency campaign basis, and can be implemented in even the most underserved populations.
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